HLFNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
HERBALIFE LTD.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$13.88−0.72 (-4.93%)
Close on Oct 19, 2026
- Market cap
- $1.45B
- P/E (TTM)
- 9.0
- Dividend yield
- –
HERBALIFE LTD. revenue by segment
By business segment
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary Reporting Segment [Member] | $1.27B | $1.26B | $1.22B | $1.20B | $1.18B | $1.16B | $1.14B | $1.17B | $1.20B | $1.19B | $1.13B | $1.19B | 95.4% | +7.4% |
| Others [Member] | $503.90M | $511.90M | $514.40M | $501.30M | $512.80M | $498.00M | $485.60M | $492.50M | $513.90M | $510.40M | $273.80M | $568.50M | 38.0% | -1.7% |
| India | $270.60M | $275.40M | $250.30M | $226.40M | $203.60M | $209.30M | $218.40M | $218.30M | $204.60M | $203.50M | $212.70M | $215.90M | 20.4% | +32.9% |
| United States | $266.30M | $241.30M | $237.00M | $256.40M | $265.30M | $247.70M | $238.50M | $253.50M | $275.30M | $258.70M | $245.90M | $270.10M | 20.1% | +0.4% |
| Mexico | $161.00M | $154.10M | $147.20M | $146.80M | $137.20M | $126.50M | $123.50M | $131.50M | $142.70M | $140.90M | $121.40M | $137.30M | 12.1% | +17.3% |
| Vietnam | $64.60M | $77.50M | $71.10M | $71.50M | $60.20M | $75.40M | $75.50M | $69.70M | $62.90M | $75.60M | – | – | 4.9% | +7.3% |
| China | $60.40M | $57.00M | $63.00M | $71.30M | $80.00M | $64.80M | $65.90M | $74.80M | $81.70M | $75.20M | $82.20M | $89.50M | 4.6% | -24.5% |
From the segment and revenue-disaggregation notes of Herbalife's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.